On November 10, 2025 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate at multiple upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
TD Cowen Immunology and Inflammation Virtual Summit
Date: Wednesday, November 12, 2025
Presentation Time: 3:00 p.m. ET / 12:00 p.m. PT
Piper Sandler 37th Annual Healthcare Conference
Date: Tuesday, December 2, 2025
Presentation Time: 2:00 p.m. ET / 11:00 a.m. PT
Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.
(Press release, Xencor, NOV 10, 2025, View Source [SID1234659730])